HealthDay News — Implementation of a computerized multidisciplinary order set in the electronic health record improves the quality of physician pharmacologic prescribing for patients hospitalized for ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic phenotype. Some 20% to 40% of COPD patients have elevated blood eosinophil counts ...

Severe COPD exacerbations are pivotal for both respiratory decline and cardiovascular vulnerability, with increased medication use post-exacerbation. Cardiovascular events occurred in 18.5% of ...

Efficacy and safety of combination therapy versus monotherapy in advanced non-small cell lung cancer: A meta-analysis of overall survival and progression-free survival. Dynamic combined monitoring of ...

Please provide your email address to receive an email when new articles are posted on . An AI had high performance in predicting COPD exacerbations using patients’ body temperature data. Thirty-seven ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The assessed COPD population included those with ...

For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to the intensive care unit (ICU), lower eosinophil counts are associated with increased in-hospital ...

GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate that as of 2019, about 400 million people around ...

VIENNA — Documenting airway thickness in patients with chronic obstructive pulmonary disease (COPD) can help physicians target eosinophilic airway inflammation with biologics, researchers suggested at ...

You did it to yourself.” This is one of the things that patients who are diagnosed with COPD often hear because of the stigma ...